[The value and association of CCR7 expression in NSCLC with lymph node metastasis.]

Tao Zeng1, Jianhu Wen, Xing Li

  • 1Department of Cardiothoracic Surgery,Mianyang 404 Hospital, Mianyang, Sichuan 621000, China. nhzengtao@yahoo.com.cn.

Abstract

Insights

CC Chemokine Receptor 7 (CCR7) is overexpressed in non-small cell lung cancer (NSCLC) tissues and correlates with lymph node metastasis. This suggests CCR7 plays a role in NSCLC

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Context:

  • Malignant tumor metastasis is a complex, selective process.
  • Non-small cell lung cancer (NSCLC) metastasis is a significant clinical challenge.
  • CC Chemokine Receptor 7 (CCR7) is implicated in tumor cell migration.

Purpose:

  • To investigate the expression of CCR7 in NSCLC tumor tissues and metastasized lymph nodes.
  • To explore the relationship between CCR7 expression and lymph node metastasis in NSCLC.
  • To determine the clinical significance of CCR7 in NSCLC progression.

Summary:

  • CCR7 expression was significantly higher in NSCLC tumor tissue compared to normal lung tissue.
  • CCR7 expression levels in tumor tissue and metastasized lymph nodes showed no significant difference.
  • Elevated CCR7 expression correlated with lymph node metastasis and advanced clinical stage in NSCLC.

Impact:

  • CCR7 is overexpressed in NSCLC, particularly in carcinoma cell nests and lymph node metastases.
  • CCR7 may be a key factor in the development and progression of lymph node metastasis in NSCLC.
  • Understanding CCR7's role could lead to targeted therapies for NSCLC metastasis.

Related Concept Videos